Cargando…
Post Hoc Subgroup Analysis of the BCause Study Assessing the Effect of AbobotulinumtoxinA on Post-Stroke Shoulder Pain in Adults
ABSTRACT: Botulinum toxin type A is approved for the focal treatment of spasticity; however, the effectiveness of abobotulinumtoxinA (aboBoNT-A) in patients with shoulder pain who have set reduced pain as a treatment goal is understudied. In addition, some patients encounter delays in accessing trea...
Autores principales: | Riberto, Marcelo, Frances, João Amaury, Chueire, Regina, Amorim, Ana Cristina Ferreira Garcia, Xerez, Denise, Chung, Tae Mo, Mercuri, Lucia Helena Costa, Lianza, Sérgio, Rocha, Eduardo Carvalho de Melo, Maisonobe, Pascal, Cuperman-Pohl, Thais, Khan, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692702/ https://www.ncbi.nlm.nih.gov/pubmed/36422983 http://dx.doi.org/10.3390/toxins14110809 |
Ejemplares similares
-
The Effectiveness of Botulinum Toxin Type A (BoNT-A) Treatment in Brazilian Patients with Chronic Post-Stroke Spasticity: Results from the Observational, Multicenter, Prospective BCause Study
por: Khan, Patricia, et al.
Publicado: (2020) -
Effectiveness of AbobotulinumtoxinA in Post-stroke Upper Limb Spasticity in Relation to Timing of Treatment
por: Wissel, Jörg, et al.
Publicado: (2020) -
Impact of abobotulinumtoxinA on the clinical features of cervical dystonia in routine practice
por: Trosch, Richard M., et al.
Publicado: (2020) -
Early AbobotulinumtoxinA (Dysport(®)) in Post-Stroke Adult Upper Limb Spasticity: ONTIME Pilot Study
por: Rosales, Raymond L, et al.
Publicado: (2018) -
The Practical Use of AbobotulinumtoxinA in Aesthetics
por: Kane, Michael A. C., et al.
Publicado: (2017)